Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.

MLA

Tsuyoshi Oguma, et al. “Clinical Contributions of Exhaled Volatile Organic Compounds in the Diagnosis of Lung Cancer.” PLoS ONE, vol. 12, no. 4, Jan. 2017, p. e0174802. EBSCOhost, https://doi.org/10.1371/journal.pone.0174802.

APA

Tsuyoshi Oguma, Takashi Nagaoka, Muneshige Kurahashi, Naofumi Kobayashi, Shinji Yamamori, Chizuko Tsuji, Hiroto Takiguchi, Kyoko Niimi, Hiromi Tomomatsu, Katsuyoshi Tomomatsu, Naoki Hayama, Takuya Aoki, Tetsuya Urano, Kazushige Magatani, Sunao Takeda, Tadashi Abe, & Koichiro Asano. (2017). Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer. PLoS ONE, 12(4), e0174802. https://doi.org/10.1371/journal.pone.0174802

Chicago

Tsuyoshi Oguma, Takashi Nagaoka, Muneshige Kurahashi, Naofumi Kobayashi, Shinji Yamamori, Chizuko Tsuji, Hiroto Takiguchi, et al. 2017. “Clinical Contributions of Exhaled Volatile Organic Compounds in the Diagnosis of Lung Cancer.” PLoS ONE 12 (4): e0174802. doi:10.1371/journal.pone.0174802.